Sljedeći

Auto Play

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 Pogledi • 07/14/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play